GLS1 regulates the dryness characteristics through ROS/Wnt/β-catenin signalling, and targeting GLS1 reduces the expression of HCC dryness-related genes and inhibits tumour metastasis in HCC [24]. The gene discussed is GLS; the disease is hepatocellular carcinoma.